Research Article
The Diagnostic Value of Serum Gastrin-17 and Pepsinogen for Gastric Cancer Screening in Eastern China
Table 3
Comparison between the diagnostic value of G-17, PGII, and PGR in gastric cancer and pathological.
| | Pathological diagnosis. Total: 834 | Sensitivity | Specificity | Accuracy | Positive predictive value | Negative predictive value | | Gastric cancer | Nongastric cancer |
| | G-17 | | Gastric cancer | 45 | 376 | 83.3% | 51.8% | 53.8% | 10.7% | 97.8% | | Nongastric cancer | 9 | 404 | | PGII | | Gastric cancer | 38 | 341 | 70.4 | 56.3% | 57.2% | 10.0% | 96.5% | | Nongastric cancer | 16 | 439 | | PGR | | Gastric cancer | 43 | 407 | 79.6% | 47.8% | 49.9% | 9.6% | 97.1% | | Nongastric cancer | 11 | 373 | | G-17 combined with PGII | | Gastric cancer | 34 | 230 | 63.0% | 70.5% | 70.0% | 12.9% | 96.5% | | Nongastric cancer | 20 | 550 | | G-17 combined with PGR | | Gastric cancer | 38 | 233 | 70.4% | 70.1% | 70.1% | 14.0% | 97.2% | | Nongastric cancer | 16 | 547 | | PGII combined with PGR | | Gastric cancer | 35 | 309 | 64.8% | 60.4% | 60.7% | 10.2% | 96.1% | | Nongastric cancer | 19 | 471 |
|
|
